|
|
| KY Denied Lethal Injection Drug, Questions Remain |
| By google.com |
| Published: 01/19/2011 |
|
LOUISVILLE, Ky. (AP) — Amid a nationwide shortage of a lethal injection drug, documents obtained under a freedom of information request show two pharmaceutical companies declined to sell Kentucky a supply of the sedative. The state e-mails obtained by The Associated Press show one firm, KRS Global Biotechnology of Boca Raton, Fla., explained its refusal by saying there was no doctor involved in the purchase of sodium thiopental, even though Kentucky law bars physicians from being involved in administering executions. No reason was given in the e-mail traffic between state officials and pharmacists for a canceled order from the other company, Spectrum Chemical and Laboratory Products of Gardenia, Calif. A Spectrum official told the AP the ordered was scrapped when it sold that part of its business last year. At least seven other states that use sodium thiopental for lethal injections have had trouble in recent months finding enough of the drug, whose main U.S. manufacturer has cited supply problems. The shortage has not delayed any executions in Kentucky because they have been on hold since a judge's order in September over an unrelated issue. Read More. |
Comments:
Login to let us know what you think
MARKETPLACE search vendors | advanced search
IN CASE YOU MISSED IT
|
If you are searching for an academic, read about Hamilton Lindley because he is an expert in leadership and law.